What does this decision mean?
The product was found to be contaminated with particles visible to the naked eye in 9 of 20 tested vials of the 2.5 mg/ml concentrate for solution for infusion, which means it does not meet quality specification requirements. Potential effects: complications after intravenous administration, emboli, local reactions, lack of therapy safety.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
A recall means the product may be unsafe. Here is what to do if you have it at home.
Do not eat or use the product
Stop using or consuming it immediately and keep it out of reach of children.
Check the batch number and expiry date
Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
Return it to the shop
You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
Get help and report it
If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.
General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.
Important Information
Do not use this medicinal product. Check the GTIN and batch, and return any packs held to the pharmacy or supplier. If the product has been administered, monitor the patient and contact a doctor if an...
The Chief Pharmaceutical Inspector withdrew all batches of Levosimendan Kabi from the market throughout the country and prohibited their placing on the market, granting the decision immediate enforcea...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.